Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- TYRO Champion Dads Project Study: Complete Statistical AnalysisIndependent statistical analysis of TYRO Champion Dads Project Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05256992).
- Tysabri JapanIndependent statistical analysis of Natalizumab (BG00002, Tysabri) Study in Japanese Participants With Relapsing-Remitting Multiple Sclerosis (RRMS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TysexIndependent statistical analysis of The Effect of Natalizumab (Tysabri) on Sexual Dysfunction in Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With Acne: Complete Statistical AnalysisIndependent statistical analysis of U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With Acne: primary endpoint results, effect estimate with confidence interval,…
- Ubiquinol (Reduced COQ10) for Patients With Sepsis: Complete Statistical AnalysisIndependent statistical analysis of Ubiquinol (Reduced COQ10) for Patients With Sepsis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01948063).
- Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses: Complete Statistical AnalysisIndependent statistical analysis of Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02276963).
- UBR ProdromeIndependent statistical analysis of Study to Evaluate Oral Ubrogepant in the Acute Treatment of Migraine During the Prodrome in Adult Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- UDB P101Independent statistical analysis of Safety and Blood Level Study of Unit Dose Budesonide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00627679).
- UGCAIndependent statistical analysis of Ustekinumab for the Treatment of Giant Cell Arteritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02955147).
- UGIH09067Independent statistical analysis of Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Ulcer Prevention Study in Post Gastric Bypass Patients: Complete Statistical AnalysisIndependent statistical analysis of Ulcer Prevention Study in Post Gastric Bypass Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00557349).
- ULIISIndependent statistical analysis of Ultrasound Liver Intraoperative Imaging With SonoVue®: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01880554).
- Ultherapy™ Treatment Following Sculptra® Treatment: Complete Statistical AnalysisIndependent statistical analysis of Ultherapy™ Treatment Following Sculptra® Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01422538).
- Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment: Complete Statistical AnalysisIndependent statistical analysis of Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Ultrasound Device for Hair Removal: Complete Statistical AnalysisIndependent statistical analysis of Ultrasound Device for Hair Removal: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01057134).
- Ultrasound Guided Adductor Canal Versus Femoral Nerve Blocks for Anterior Cruciate Ligament Reconstruction in Pediatrics: Complete Statistical AnalysisIndependent statistical analysis of Ultrasound Guided Adductor Canal Versus Femoral Nerve Blocks for Anterior Cruciate Ligament Reconstruction in Pediatrics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Ultrasound Method to Measure Fibrosis of the Liver in Children: Complete Statistical AnalysisIndependent statistical analysis of Ultrasound Method to Measure Fibrosis of the Liver in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02086708).
- Ultrasound Prediction of Prolonged Labour: Complete Statistical AnalysisIndependent statistical analysis of Ultrasound Prediction of Prolonged Labour: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00915148).
- Ultrasound-guided Intermediate Cervical Plexus Block: Complete Statistical AnalysisIndependent statistical analysis of Ultrasound-guided Intermediate Cervical Plexus Block: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02794974).
- Ultrasound-Guided Landmark and Epidural Site Pain: Complete Statistical AnalysisIndependent statistical analysis of Ultrasound-Guided Landmark and Epidural Site Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02813681).
- Ultrasound-Monitored Changes in Achilles Tendinopathy After Extracorporeal Shock Wave Therapy: Complete Statistical AnalysisIndependent statistical analysis of Ultrasound-Monitored Changes in Achilles Tendinopathy After Extracorporeal Shock Wave Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04780919).
- ULYM11011Independent statistical analysis of Imexon for Relapsed Follicular and Aggressive Lymphomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01314014).
- Umbilical & Cord Blood (CB) Derived CAR-Engineered NK Cells for B Lymphoid Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Umbilical & Cord Blood (CB) Derived CAR-Engineered NK Cells for B Lymphoid Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- UNCOVER-3Independent statistical analysis of A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01646177).
- Understanding Non-Response in Spine Fusion Surgery: Complete Statistical AnalysisIndependent statistical analysis of Understanding Non-Response in Spine Fusion Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02611479).
- Understanding the Sleep Apnea/Insomnia Interaction: Complete Statistical AnalysisIndependent statistical analysis of Understanding the Sleep Apnea/Insomnia Interaction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01824472).
- Underutilization of Hospice in Older African Americans: Complete Statistical AnalysisIndependent statistical analysis of Underutilization of Hospice in Older African Americans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04458090).
- Undiagnosed Hepatitis C Infection in an Urban Hospital: Complete Statistical AnalysisIndependent statistical analysis of Undiagnosed Hepatitis C Infection in an Urban Hospital: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01957085).
- UNIFIIndependent statistical analysis of A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis: primary endpoint results, effect estimate…
- UNIKIndependent statistical analysis of A Non-inferiority, Comparative Study Between Foraseq®, Eurofarma´s Formoterol/Budesonide and Alenia® in Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- UNITE Study: Understanding New Interventions With GBM ThErapy: Complete Statistical AnalysisIndependent statistical analysis of UNITE Study: Understanding New Interventions With GBM ThErapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03419403).
- Unite-CNMIndependent statistical analysis of Early Phase Human Drug Trial to Investigate Dynamin 101 (DYN101) in Patients ≥ 16 Years With Centronuclear Myopathies: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- UNTOUCHEDIndependent statistical analysis of Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- UPLIFTIndependent statistical analysis of Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- UPLIFT-BoneIndependent statistical analysis of Utilizing Protein During Weight Loss to Impact Physical Function and Bone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Upper Extremity Lymphatic Mapping for Breast Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Upper Extremity Lymphatic Mapping for Breast Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00717886).
- upreACH-2Independent statistical analysis of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SAR442501 in Pediatric Participants With Achondroplasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- UPSTARTIndependent statistical analysis of Using Peer Support to Aid in Prevention and Treatment in Prediabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- UPTIndependent statistical analysis of Uterotonic Prophylaxis Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02408965).
- Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder: Complete Statistical AnalysisIndependent statistical analysis of Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- UPWARDIndependent statistical analysis of A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide: primary endpoint results, effect estimate with confidence interval,…
- UrApp for Childhood Nephrotic Syndrome Management (Incident Cohort): Complete Statistical AnalysisIndependent statistical analysis of UrApp for Childhood Nephrotic Syndrome Management (Incident Cohort): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04075656).
- Urease Breath Test for Rapid Characterization of Pneumonia: Complete Statistical AnalysisIndependent statistical analysis of Urease Breath Test for Rapid Characterization of Pneumonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03100760).
- Uric Acid and the Endothelium in CKD: Complete Statistical AnalysisIndependent statistical analysis of Uric Acid and the Endothelium in CKD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01228903).
- Urinalysis Results in Healthy Individuals: Complete Statistical AnalysisIndependent statistical analysis of Urinalysis Results in Healthy Individuals: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04055675).
- Urinary Proanthocyanidin-A2 as a Biomarker of Compliance to Intake of Cranberry Products: Complete Statistical AnalysisIndependent statistical analysis of Urinary Proanthocyanidin-A2 as a Biomarker of Compliance to Intake of Cranberry Products: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Urinary Retention After Total Laparoscopic Hysterectomy With Immediate Foley Catheter Removal Versus Backfill Void Trial: Complete Statistical AnalysisIndependent statistical analysis of Urinary Retention After Total Laparoscopic Hysterectomy With Immediate Foley Catheter Removal Versus Backfill Void Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Urinary Track Infection Prevention After Urogynecological Surgery: Complete Statistical AnalysisIndependent statistical analysis of Urinary Track Infection Prevention After Urogynecological Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03818321).